# Contrast Enhancement on Coronary Computed Tomographic Angiography

Study · id `cardio:ct-nct02462044` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02462044](<https://clinicaltrials.gov/study/NCT02462044>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02462044

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

## Technical summary

Registry record NCT02462044. Randomized; double masking; primary purpose diagnostic. Start 2014-08 (registry gives no type); primary completion 2015-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose diagnostic
- Phase: Phase 4
- Enrolled: 200 participants (enrolled count; ClinicalTrials.gov record NCT02462044, source copy `cardio:ctgov-nct02462044-2016-01-05`, retrieved 2026-10-26)
- Start date: 2014-08 (registry gives no type) (ClinicalTrials.gov record NCT02462044, source copy `cardio:ctgov-nct02462044-2016-01-05`, retrieved 2026-10-26)
- Primary completion: 2015-08 (actual) (ClinicalTrials.gov record NCT02462044, source copy `cardio:ctgov-nct02462044-2016-01-05`, retrieved 2026-10-26)
- Completion: 2015-09 (actual) (ClinicalTrials.gov record NCT02462044, source copy `cardio:ctgov-nct02462044-2016-01-05`, retrieved 2026-10-26)
- Countries: Netherlands (ClinicalTrials.gov record NCT02462044, source copy `cardio:ctgov-nct02462044-2016-01-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02462044-2016-01-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Contrast Enhancement on Coronary Computed Tomographic Angiography
- Acronym: EICAR
- Condition: Coronary Artery Disease
- Condition: Coronary Stenosis
- Intervention (Drug): 240 mg Iodine
- Intervention (Drug): 300 mg Iodine
- Intervention (Drug): 370 mg Iodine
- Lead sponsor: Maastricht University Medical Center
- Lead sponsor class: OTHER
- Collaborator: Bayer
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Maastricht University Medical Center (`cardio:org-maastricht-university-medical-center`)
- Registry lists this organization as a collaborator: Bayer (`cardio:bayer`)

## Provenance

Content hash: caa36970291e3f896678ec6ec58430f15af52173613b949831dfbf6635e66a42
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
